Silence Therapeutics (SLN) Prepaid Assets (2018 - 2026)
Silence Therapeutics' (SLN) quarterly Prepaid Assets came in at $10.6 million in Q1 2026, down 35.7% year-on-year from $16.4 million in Q1 2025, and down 8.49% quarter-over-quarter from $11.5 million in Q4 2025.
Silence Therapeutics (SLN) Prepaid Assets (2018 - 2026) Analysis & Trends
Silence Therapeutics has disclosed Prepaid Assets across 9 years of filings, most recently posting $10.6 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $10.6 million, down 35.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.6 million (down 35.7% YoY), and the FY2025 annual result was $11.5 million, down 21.32% from the prior year.
- Prepaid Assets came in at $10.6 million for Q1 2026 at Silence Therapeutics, down from $11.5 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $16.4 million in Q1 2025 to a low of $9.3 million in Q3 2025.
- The 5-year median for Prepaid Assets is $11.0 million (2025), against an average of $12.1 million.
- Across the five-year window, Prepaid Assets soared 65.58% in 2022 and tumbled 35.7% in 2026, its largest moves.
- Silence Therapeutics' Prepaid Assets stood at $9.6 million in 2022, then gained by 5.26% to $10.1 million in 2023, then surged by 44.84% to $14.7 million in 2024, then declined by 21.32% to $11.5 million in 2025, then retreated by 8.49% to $10.6 million in 2026.
- The last three Prepaid Assets figures came in at $10.6 million (Q1 2026), $11.5 million (Q4 2025), and $9.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Silence Therapeutics | 966.41 Mn | 896.33 Mn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.56 Mn |
| Dec 31, 2025 | 11.54 Mn |
| Sep 30, 2025 | 9.26 Mn |
| Jun 30, 2025 | 14.36 Mn |
| Mar 31, 2025 | 16.42 Mn |
| Dec 31, 2024 | 14.66 Mn |
| Dec 31, 2023 | 10.12 Mn |
| Dec 31, 2022 | 9.62 Mn |
| Dec 31, 2021 | 5.81 Mn |
| Dec 31, 2020 | 5.20 Mn |
| Dec 31, 2019 | 554,147.43 |
| Dec 31, 2018 | 662,685.12 |